An EGFR-mutant lung cancer cell line exposed to EGFR/MEK inhibition in vitro through a combination of osimertinib and trametinib (via a DMSO-containing solution of 100 nM and 30 nM of the former and latter agents respectively) induced a widespread apoptotic response. This evidence concerns the gene EGFR and lung carcinoma.